Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Response to Pazopanib in Patients With Relapsed Osteosarcoma
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Response to Pazopanib in Patients With Relapsed Osteosarcoma'. Together they form a unique fingerprint.
Pazopanib
Keyphrases
100%
Relapsed Osteosarcoma
Keyphrases
100%
Osteosarcoma
Medicine and Dentistry
100%
Chemotherapy
Keyphrases
33%
Positive Responses
Keyphrases
33%
Tyrosine Kinase Inhibitor
Keyphrases
33%
Targeted Therapy
Keyphrases
33%
Soft Tissue Sarcoma
Keyphrases
33%
Cite this